A
Andrew M. Moon
Researcher at University of North Carolina at Chapel Hill
Publications - 78
Citations - 3137
Andrew M. Moon is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 16, co-authored 52 publications receiving 1596 citations. Previous affiliations of Andrew M. Moon include Duke University & University of Washington.
Papers
More filters
Journal ArticleDOI
Evaluation of In-Hospital Management for Febrile Illness in Northern Tanzania before and after 2010 World Health Organization Guidelines for the Treatment of Malaria
Andrew M. Moon,Holly M. Biggs,Matthew P. Rubach,John A. Crump,Venace P. Maro,Venace P. Maro,Wilbrod Saganda,Elizabeth A. Reddy +7 more
TL;DR: Differences in historic and recent hospital cohorts in the diagnosis and treatment of febrile illness in a low malaria prevalence area of northern Tanzania are assessed to assess changes in the treatment of malaria and bacterial infections.
Journal ArticleDOI
Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis
TL;DR: Although vaccination, screening, and anti-viral treatment campaigns for hepatitis B and C have reduced CLD burden in some parts of the world, concomitant increases in injection drug use, alcohol misuse and metabolic syndrome threaten these trends.
Journal ArticleDOI
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study.
Thomas Marjot,Andrew M. Moon,Jonathan Cook,Sherief Abd-Elsalam,Costica Aloman,Matthew J. Armstrong,Elisa Pose,Erica J. Brenner,Tamsin Cargill,Maria-Andreea Catana,Renumathy Dhanasekaran,Ahad Eshraghian,Ignacio García-Juárez,Upkar S. Gill,Patricia D. Jones,James Kennedy,Aileen Marshall,Charmaine Matthews,George F. Mells,Carolyn Mercer,Ponni V. Perumalswami,Emma Avitabile,Xialong Qi,Feng Su,Nneka N. Ufere,Yu Jun Wong,Ming-Hua Zheng,Eleanor Barnes,Alfred S. Barritt,Gwilym J. Webb,Gwilym J. Webb +30 more
TL;DR: It is demonstrated that baseline liver disease stage and ALD are independent risk factor for death from COVID-19, which is the largest reported cohort of CLD and cirrhosis patients with SARS-CoV-2 infection to date.
Journal ArticleDOI
COVID-19 and liver disease: mechanistic and clinical perspectives.
Thomas Marjot,Gwilym J. Webb,Alfred S. Barritt,Andrew M. Moon,Zania Stamataki,Vincent Wai-Sun Wong,Eleanor Barnes +6 more
TL;DR: In this article, the authors discuss the hepatotropism of SARS-CoV-2, including the differential expression of viral receptors on liver cell types, and describe the liver histology features present in patients with COVID-19.
Journal ArticleDOI
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry.
Andrew M. Moon,Gwilym J. Webb,Costica Aloman,Matthew J. Armstrong,Tamsin Cargill,Renumathy Dhanasekaran,Joan Genescà,Upkar S. Gill,Theodore W. James,Patricia D. Jones,Aileen Marshall,George F. Mells,Ponni V. Perumalswami,Xiaolong Qi,Feng Su,Nneka N. Ufere,Eleanor Barnes,A. Sidney Barritt,Thomas Marjot +18 more